Selection of patients for beta-blocking treatment after myocardial infarction.
Based on published studies of patients the following conclusions may be made: a) Long-term mortality and reinfarction rate can be reduced; b) No practically effective or meaningful restricted selection of patients for treatment with beta blockers is possible; c) Treatment starting when patients have stabilized in hospital usually after 5-7 days is well documented; d) Treatment should be maintained 2-3 years and the individual indications should then be re-evaluated; e) beta Blockers other than timolol, propranolol, metoprolol and alprenolol have yet to be documented.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D013997:Time Factors
D000319:Adrenergic beta-Antagonists